Recruitment of immune and inflammatory cells in the microenvironment of solid tumors is highly heterogeneous and follows patterns, varying according to the organ of origin and stage of disease, with critical roles in the process of cancer onset and progression. While adaptive cells are endowed with anti-tumor activities, inflammatory components of the immune infiltrate orchestrate an immunosuppressive microenvironment that reveals ambivalent functions of the immune contexture in the tumor milieu. The balance between opposing pro-tumoral and anti-tumoral immune pathways, which occur concomitantly in the tumor microenvironment, and the regulatory networks of these phenomena have been the target of several immunotherapeutic strategies. While the scarcity of adaptive immune effectors in tumors correlates with dismal prognosis, the pathways of activation of tumor-specific lymphocytes are yet to be fully elucidated. Recently, the occurrence of tertiary lymphoid tissue was revealed to be critical in mediating the dynamics of T cell recruitment and local activation of immune cells in the tumor microenvironment. Thus, tertiary lymphoid tissue assessment and targeting emerge as a promising approach for the design of novel prognostic immune signatures and immunotherapeutic strategies. The immunological behavior of tertiary lymphoid tissue, its occurrence in the tumor immune microenvironment and its clinical relevance are discussed here.

Tertiary lymphoid tissue in the tumor microenvironment : from its occurrence to immunotherapeutic implications / G. Di Caro, G.F. Castino, F. Bergomas, N. Cortese, M. Chiriva-Internati, F. Grizzi, A. Mantovani, F. Marchesi. - In: INTERNATIONAL REVIEWS OF IMMUNOLOGY. - ISSN 0883-0185. - 34:2(2015), pp. 123-133. [10.3109/08830185.2015.1018416]

Tertiary lymphoid tissue in the tumor microenvironment : from its occurrence to immunotherapeutic implications

M. Chiriva-Internati;A. Mantovani;F. Marchesi
Ultimo
2015

Abstract

Recruitment of immune and inflammatory cells in the microenvironment of solid tumors is highly heterogeneous and follows patterns, varying according to the organ of origin and stage of disease, with critical roles in the process of cancer onset and progression. While adaptive cells are endowed with anti-tumor activities, inflammatory components of the immune infiltrate orchestrate an immunosuppressive microenvironment that reveals ambivalent functions of the immune contexture in the tumor milieu. The balance between opposing pro-tumoral and anti-tumoral immune pathways, which occur concomitantly in the tumor microenvironment, and the regulatory networks of these phenomena have been the target of several immunotherapeutic strategies. While the scarcity of adaptive immune effectors in tumors correlates with dismal prognosis, the pathways of activation of tumor-specific lymphocytes are yet to be fully elucidated. Recently, the occurrence of tertiary lymphoid tissue was revealed to be critical in mediating the dynamics of T cell recruitment and local activation of immune cells in the tumor microenvironment. Thus, tertiary lymphoid tissue assessment and targeting emerge as a promising approach for the design of novel prognostic immune signatures and immunotherapeutic strategies. The immunological behavior of tertiary lymphoid tissue, its occurrence in the tumor immune microenvironment and its clinical relevance are discussed here.
Biomarker; Immune infiltration; Prognosis; Tertiary Lymphoid Tissue; Immunology; Immunology and Allergy
Settore MED/04 - Patologia Generale
2015
Article (author)
File in questo prodotto:
File Dimensione Formato  
08830185.2015.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 385.79 kB
Formato Adobe PDF
385.79 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/326479
Citazioni
  • ???jsp.display-item.citation.pmc??? 17
  • Scopus 28
  • ???jsp.display-item.citation.isi??? 26
social impact